DE2355204A1 - Pharmazeutische allopurinol-enthaltende zubereitungen und verfahren zu ihrer herstellung - Google Patents

Pharmazeutische allopurinol-enthaltende zubereitungen und verfahren zu ihrer herstellung

Info

Publication number
DE2355204A1
DE2355204A1 DE19732355204 DE2355204A DE2355204A1 DE 2355204 A1 DE2355204 A1 DE 2355204A1 DE 19732355204 DE19732355204 DE 19732355204 DE 2355204 A DE2355204 A DE 2355204A DE 2355204 A1 DE2355204 A1 DE 2355204A1
Authority
DE
Germany
Prior art keywords
allopurinol
tablet
tablet formulation
formulation according
minutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19732355204
Other languages
German (de)
English (en)
Inventor
David Harden
Henry J Kessler
Allan John Torode
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of DE2355204A1 publication Critical patent/DE2355204A1/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19732355204 1972-11-06 1973-11-05 Pharmazeutische allopurinol-enthaltende zubereitungen und verfahren zu ihrer herstellung Pending DE2355204A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5105072A GB1445983A (en) 1972-11-06 1972-11-06 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
DE2355204A1 true DE2355204A1 (de) 1974-05-16

Family

ID=10458450

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19732355204 Pending DE2355204A1 (de) 1972-11-06 1973-11-05 Pharmazeutische allopurinol-enthaltende zubereitungen und verfahren zu ihrer herstellung

Country Status (14)

Country Link
JP (1) JPS577127B2 (sl)
AU (1) AU467532B2 (sl)
BE (1) BE806946A (sl)
CA (1) CA975297A (sl)
CH (1) CH583734A5 (sl)
CY (1) CY940A (sl)
DE (1) DE2355204A1 (sl)
FR (1) FR2205309B1 (sl)
GB (1) GB1445983A (sl)
HK (1) HK1278A (sl)
IL (1) IL43562A (sl)
KE (1) KE2807A (sl)
MY (1) MY7800180A (sl)
ZA (1) ZA738489B (sl)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2506099A1 (de) * 1974-02-14 1975-08-21 Wellcome Found Pharmazeutische formulierungen zur oralen verabfolgung
US4143129A (en) 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2608045B1 (fr) * 1986-12-12 1990-03-02 Chauvin Laboratoires Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB975850A (en) * 1955-08-10 1964-11-18 Wellcome Found Xanthine oxidase inhibitors

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2506099A1 (de) * 1974-02-14 1975-08-21 Wellcome Found Pharmazeutische formulierungen zur oralen verabfolgung
US4143129A (en) 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets

Also Published As

Publication number Publication date
CY940A (en) 1978-06-23
KE2807A (en) 1978-02-17
CH583734A5 (sl) 1977-01-14
AU467532B2 (en) 1975-12-04
FR2205309B1 (sl) 1976-04-09
JPS49133517A (sl) 1974-12-21
CA975297A (en) 1975-09-30
HK1278A (en) 1978-01-13
JPS577127B2 (sl) 1982-02-09
IL43562A0 (en) 1974-03-14
GB1445983A (en) 1976-08-11
ZA738489B (en) 1975-02-26
AU6217773A (en) 1975-05-08
BE806946A (fr) 1974-05-06
IL43562A (en) 1976-08-31
MY7800180A (en) 1978-12-31
FR2205309A1 (sl) 1974-05-31

Similar Documents

Publication Publication Date Title
DE69730834T2 (de) Verfahren zur herstellung von festen oralen dosierungsformen von valsartan
DE69434479T2 (de) Tramadolhaltiges Arzneimittel mit gesteuerter Wirkstoffabgabe
DE60133538T2 (de) Formulierung und tabletten mit guaifenesin mit verzögerter freisetzung
DE68903846T2 (de) Neue galenische form von fenofibrat.
AT394310B (de) Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge
DE69332463T2 (de) Niacin enthaltende Tabletten und Sätze mit verzögerter Wirkstoffabgabe
DE69903404T2 (de) Celecoxib-Zusammensetzungen
DE69735644T2 (de) Nateglinide zubereitung in tablettenform
DE69128569T2 (de) Tablette mit verzögerter Wirkstoffabgabe
CH662947A5 (de) Sich schnell aufloesende, pharmazeutische zubereitung sowie verfahren zu ihrer herstellung.
EP0439030B1 (de) Orale Arzneimittelformen von Pimobendan
DE69913197T2 (de) Natriumhydrogendivalproat-formulierungen mit gesteuerter freigabe
DE9321574U1 (de) Tabletten, Granulate und Pellets mit hohem Gehalt an Wirkstoffen für hochkonzentrierte, feste Darreichungsformen
DE69429964T2 (de) Feste, therapeutische oder hygienische, mucoadhäsive Zusammensetzung zur Verabreichung durch Auftragen auf der Mund-schleimhaut oder der Nasen-schleimhaut
DE69513254T2 (de) Gepirone enthaltende Zusammensetzungen
DE2816055A1 (de) Neuer excipient und diesen enthaltende pharmazeutische zusammensetzung
DE3431861A1 (de) Pellet-zubereitung
DE1927130A1 (de) Depotarzneimittel in Tablettenform
DE69814850T2 (de) Paracetamol enthaltende schlickbare tablette
DE69518237T2 (de) Feste pharmazeutische zubereitung mit (s)-2-(4-isobutylphenyl)propionsäure als wirkstoff und mikrokristalliner cellulose und kolloidalem silica als hilfstoff
EP1077703B1 (de) Orale arzneiformen mit reproduzierbarer wirkstofffreisetzung von gatifloxacin oder pharmazeutisch verwendbaren salzen oder hydraten
AT399277B (de) Festes pharmazeutisches piroxicam-präparat und verfahren zu seiner herstellung
DE3232873A1 (de) Pharmazeutisches praeparat
DE69624364T2 (de) Abführmittel enthaltend lactitol und psyllium
DE2128461A1 (de) Pharmazeutisches Präparat

Legal Events

Date Code Title Description
OHN Withdrawal